Results 161 to 170 of about 22,830 (226)

ROS1 Fusion Positive [PDF]

, 2020
openaire   +1 more source

[Clinicopathological Characteristics of ROS1-positive 
Non-small Cell Lung Cancer Based on Next-generation Sequencing]. [PDF]

Zhongguo Fei Ai Za Zhi
Gao L, Sun L, Li W, Mu J, Qiao J, Guo L.
europepmc   +1 more source

ROS1 Fusion Negative [PDF]

, 2020
openaire   +1 more source

A predictive model for fusion gene positivity in treatment-naive advanced non-small cell lung cancer. [PDF]

Transl Lung Cancer Res
Wang Y, Xie Y, Yao X, Ke K, Ma P, Wang F, Liu Q, Xie X, Liu M, Lin X, Zhou C, Xie Z.   +11 more
europepmc   +1 more source

Association of PD-L1 expression and clinical outcomes in ROS1-rearranged advanced non-small cell lung cancer treated with entrectinib. [PDF]

Transl Lung Cancer Res
Chen L, Shi W, Cao Z, Lu L, Wang A, Sun J, Ouyang Y, Xu P, Tang J, Li Z.   +9 more
europepmc   +1 more source

ROS1 Gene Inversion [PDF]

, 2020
openaire   +1 more source

Lung Cancer in Never Smokers-An Underappreciated Public Health Burden. [PDF]

Health Sci Rep
Mohiuddin M.
europepmc   +1 more source

Toward targeted therapeutics for lobular breast cancer. [PDF]

J Clin Invest
Fanucci KA, Bahnassy S, Roy AM, Sokolova A, Stover DG, Simpson PT, Riggins RB, Jeselsohn R.   +7 more
europepmc   +1 more source

Case Report: A case series on actionable genomic alterations guiding effective targeted therapy in rare sarcomas. [PDF]

Front Oncol
Zeal JL, Woodcock MG, Chen KY, Stein JN.
europepmc   +1 more source

Cancer Drug Development in Never-Smoker Lung Cancer: Targeted and Immune-Based Therapeutic Strategies. [PDF]

Oncol Res
Cojocaru C, Costuleanu M, Petriș OR, Cojocaru R, Vasîncu D, Cojocaru E.   +5 more
europepmc   +1 more source